Beckman Coulter SARS-CoV-2 IgM Antibody Test Receives FDA EUA
The assay detects antibodies that recognize the receptor binding domain of the spike protein which the SARS-CoV-2 virus uses to enter the human host cells.
Read MorePosted by Laurie Bonner | Oct 9, 2020 | Covid 19, Immunoassay Reagents & test Kits |
The assay detects antibodies that recognize the receptor binding domain of the spike protein which the SARS-CoV-2 virus uses to enter the human host cells.
Read MorePosted by Laurie Bonner | Oct 9, 2020 | Covid 19, Lab Management |
New code additions and editorial revisions for reporting medical services were sparked by the public health response to the covid-19 pandemic.
Read MorePosted by Melanie Hamilton-Basich | Oct 8, 2020 | Covid 19, Immunoassay |
Inflammatix, Burlingame, Calif, a pioneering molecular diagnostics company, announced that the...
Read MorePosted by Laurie Bonner | Oct 8, 2020 | Covid 19, Molecular Diagnostics |
The RP2 Panel provides results in less than 2 hours for more than 20 viruses and bacteria that cause common respiratory infections with similar symptoms, including covid-19, flu, bronchitis and the common cold.
Read MorePosted by Laurie Bonner | Oct 7, 2020 | Covid 19, Flu & Respiratory Infections, POC Rapid Assays |
The Sofia 2 Flu + SARS Antigen FIA point-of-care test delivers three results from one sample in 15 minutes.
Read More